Heart Failure With Preserved Ejection Fraction trials recruiting in Minnesota

All Heart Failure With Preserved Ejection Fraction trials nationally

Cities in Minnesota

Recruiting trials in Minnesota

• A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
  NCT07093528 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Rochester
• A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure
  NCT07083011 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Rochester
• Assessment of CCM in HF With Higher Ejection Fraction
  NCT05064709 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Minneapolis
• Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction
  NCT07401771 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · Minnesota: Rochester
• HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
  NCT05873634 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female) · Minnesota: Rochester
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Minnesota: Mankato, Maplewood, Minneapolis
• Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
  NCT06517186 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female) · Minnesota: Rochester
• The PeriCut Catheter System Early Feasibility Study (REIMAGINE-HFpEF)
  NCT06702501 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years and older · Sex: All (male and female) · Minnesota: Rochester